Padraig O'Suilleabhain, MD

Associate Professor
Neurology and Neurotherapeutics

Contact Information

UT Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, Texas 75390

padraig.osuilleabhain@utsouthwestern.edu

To make an appointment, call 214-645-8300.

Education

Research FellowMayo Clinic College of Medicine, Neurology (1998)
FellowshipMayo Clinic College of Medicine, Movement Disorders (1997)
ResidencyMayo Clinic College of Medicine, Neurology (1996)
InternshipMayo Clinic College of Medicine, Medicine (1993)
InternshipSri Venkateswara University, Medicine (1992)
Medical SchoolUniversity of Dublin (1991)

Research Interests

Deep brain stimulation for treatment of tremor
Homocysteine in Parkinson disease
Huntington disease disease modification
Pesticides in Parkinson disease
SPECT scan diagnosis of Parkinson disease

Publications

Featured
Distinguishing neurogenic from non-neurogenic detrusor overactivity: a urodynamic assessment of lower urinary tract symptoms in patients with and without Parkinson’s disease.

Defreitas GA, Lemack GE, Zimmern PE, Dewey RB, Roehrborn CG, O’Suilleabhain PE. , Urology , October 2003; (62(4)):651-5

Featured
Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs.

O’Suilleabhain P, Giller C. , Movement disorders : official journal of the Movement Disorder Society , November 2003; (18(11)):1378-81

Featured
Levodopa elevates homocysteine: is this a problem?

O’Suilleabhain P, Diaz-Arrastia R. , Archives of neurology , May 2004; (61(5)):633-4

Featured
Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations.

O’Suilleabhain PE, Sung V, Hernandez C, Lacritz L, Dewey RB Jr, Bottiglieri T, Diaz-Arrastia R. , Archives of neurology , June 2004; (61 (6)):865-8

Featured
Movement disorders after head injury: diagnosis and management.

O’Suilleabhain P, Dewey RB Jr. , The Journal of head trauma rehabilitation , July 2004; (19(4)):305-13

Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease.

Dewey RB 2nd, Reimold SC, O’Suilleabhain PE. , Archives of neurology , March 2007; (64(4)):377-80

Parkinson disease with severe tremor but otherwise mild deterioration.

O’Suilleabhain PE. , Archives of neurology , March 2006; (63(3)):321-2

Clinical course in Parkinson’s disease with elevated homocysteine.

O’Suilleabhain PE, Oberle R, Bartis C, Dewey RB Jr, Bottiglieri T, Diaz-Arrastia R. , Parkinsonism & related disorders , March 2006; (12(2)):103-7

Pergolide use in Parkinson disease is associated with cardiac valve regurgitation.

Baseman DG, O’Suilleabhain PE, Reimold SC, Laskar SR, Baseman JG, Dewey RB Jr. , Neurology , July 2004; (63(2)):301-4

Modest increase in plasma homocysteine follows levodopa initiation in Parkinson’s disease.

O’Suilleabhain PE, Bottiglieri T, Dewey RB Jr, Sharma S, Diaz-Arrastia R. , Movement disorders : official journal of the Movement Disorder Society , December 2004; (19(12)):1403-8

Professional Associations/Affiliations

American Association of Neurologists

American Medical Association

Dallas County Medical Society

Movement Disorder Society

Texas Neurological Association